NewLimit
NewLimit is a biotechnology company that focuses on extending human healthspan through epigenetic reprogramming of cells. The company develops innovative medicines aimed at restoring youthful function in aging cells, targeting age-related diseases. NewLimit employs cutting-edge research to explore the potential of cellular rejuvenation, contributing to advancements in biomedicine. By utilizing epigenetic techniques, the company seeks to provide solutions that enhance the quality of life as individuals age. Its approach represents a significant shift in how age-related conditions are understood and treated, paving the way for new therapeutic options.
Domain
newlimit.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$45.0M
Founded
2021
Tech Stack (7 technologies)
Frequently Asked Questions
What technologies does NewLimit use?+
NewLimit uses 7 technologies including Google Analytics, Google Tag Manager, Webflow.
What industry is NewLimit in?+
NewLimit operates in the Biotechnology industry.
Where is NewLimit based?+
NewLimit is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026